OABI Stock Analysis: Buy, Sell, or Hold?
OABI - OmniAb, Inc. Common Stock
$1.82
-0.04 (-2.15%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 17, 2026
Get Alerted When OABI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OABI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OABI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OABI is currently trading at $1.82, which is considered fair relative to its 30-day fair value range of $1.87 to $1.98.
Technical Outlook: Technically, OABI is in a strong uptrend. Immediate support is located at $1.76, while resistance sits at $2.10.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.33 (+294.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OABI is in a strong uptrend. Immediate support is located at $1.76, while resistance sits at $2.10.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.33 (+294.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.87 -
$1.98
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding OABI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 294.3% below Wall St target ($7.33)
- CAUTION: Recommendation downgraded due to -7.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.87 -
$1.98
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.76
Resistance Level
$2.10
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.46
Wall Street Target
$7.33
(+294.3%)
Revenue Growth (YoY)
-46.3%
Last updated: January 30, 2026 5:42 PM ET
Data refreshes hourly during market hours. Next update: 6:42 PM
Data refreshes hourly during market hours. Next update: 6:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OABI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
Advanced OABI Option Strategies
Professional options setups generated by AI based on today's OABI price and gamma walls.
